Vinay K. Puduvalli
Department of Neuro-Oncology
University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd.
Houston
USA
Name/email consistency: high
- Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Puduvalli, V.K., Giglio, P., Groves, M.D., Hess, K.R., Gilbert, M.R., Mahankali, S., Jackson, E.F., Levin, V.A., Conrad, C.A., Hsu, S.H., Colman, H., de Groot, J.F., Ritterhouse, M.G., Ictech, S.E., Yung, W.K. Neuro-oncology (2008)
- TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation. Puduvalli, V.K., Sampath, D., Bruner, J.M., Nangia, J., Xu, R., Kyritsis, A.P. Apoptosis (2005)
- Induction of apoptosis in primary meningioma cultures by fenretinide. Puduvalli, V.K., Li, J.T., Chen, L., McCutcheon, I.E. Cancer Res. (2005)
- Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. Puduvalli, V.K., Yung, W.K., Hess, K.R., Kuhn, J.G., Groves, M.D., Levin, V.A., Zwiebel, J., Chang, S.M., Cloughesy, T.F., Junck, L., Wen, P., Lieberman, F., Conrad, C.A., Gilbert, M.R., Meyers, C.A., Liu, V., Mehta, M.P., Nicholas, M.K., Prados, M. J. Clin. Oncol. (2004)
- Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Puduvalli, V.K., Hashmi, M., McAllister, L.D., Levin, V.A., Hess, K.R., Prados, M., Jaeckle, K.A., Yung, W.K., Buys, S.S., Bruner, J.M., Townsend, J.J., Davis, R., Sawaya, R., Kyritsis, A.P. Oncology (2003)
- Brain metastases: biology and the role of the brain microenvironment. Puduvalli, V.K. Curr. Oncol. Rep (2001)
- Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors. Puduvalli, V.K., Sawaya, R. J. Neurooncol. (2000)